We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$84.7B
AUM Growth
+$3.15B
Cap. Flow
-$3.2B
Cap. Flow %
-3.77%
Top 10 Hldgs %
10.93%
Holding
2,264
New
35
Increased
617
Reduced
853
Closed
525

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$128M
2
DHR icon
Danaher
DHR
+$114M
3
ZBRA icon
Zebra Technologies
ZBRA
+$112M
4
AIZ icon
Assurant
AIZ
+$92.7M
5
EXC icon
Exelon
EXC
+$92.2M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.17%
3 Financials 13.51%
4 Industrials 10.72%
5 Consumer Discretionary 9.33%

Similar funds

Macquarie Group's Q4 2022 Portfolio in Review

As of Q4 2022, Macquarie Group held 2,264 positions worth $84.7B, up 3.9% from $81.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group withdrew a net $3.2B in Q4 2022, closing 525 positions and reducing 853 holdings. Its most notable exit was Abiomed Inc, an estimated $124M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in iShares 0-5 Year Investment Grade Corporate Bond ETF worth $58.3M.

  • Macquarie Group's largest Q4 2022 buy was iShares 0-5 Year Investment Grade Corporate Bond ETF: 1,218,670 shares worth $58.3M.
  • Macquarie Group added most to L3Harris in Q4 2022, an estimated $128M increase.
  • Macquarie Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $189M.
  • Macquarie Group fully exited Abiomed Inc in Q4 2022, selling an estimated $124M.
  • Macquarie Group's ten largest holdings make up 11% of its $84.7B portfolio in Q4 2022.
  • Macquarie Group opened 35 new positions and closed 525 in Q4 2022.
  • Macquarie Group's portfolio value rose 3.9% quarter-over-quarter to $84.7B.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.